A detailed history of Parus Finance (Uk) LTD transactions in Novo Nordisk A S stock. As of the latest transaction made, Parus Finance (Uk) LTD holds 6,246 shares of NVO stock, worth $658,078. This represents 0.26% of its overall portfolio holdings.

Number of Shares
6,246
Previous 4,940 26.44%
Holding current value
$658,078
Previous $634,000 40.54%
% of portfolio
0.26%
Previous 0.24%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

BUY
$122.71 - $146.91 $160,259 - $191,864
1,306 Added 26.44%
6,246 $891,000
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $504,423 - $671,444
4,940 New
4,940 $634,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Parus Finance (Uk) LTD Portfolio

Follow Parus Finance (Uk) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parus Finance (Uk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Parus Finance (Uk) LTD with notifications on news.